{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T09:57:50Z","timestamp":1791107870738,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1124\/mol.110.067256","type":"journal-article","created":{"date-parts":[[2010,11,5]],"date-time":"2010-11-05T21:07:53Z","timestamp":1288991273000},"page":"241-250","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":81,"title":["Itraconazole-Induced Cholestasis: Involvement of the Inhibition of Bile Canalicular Phospholipid Translocator MDR3\/ABCB4"],"prefix":"10.1016","volume":"79","author":[{"given":"Takashi","family":"Yoshikado","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tappei","family":"Takada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takehito","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroko","family":"Yamaji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kousei","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomofumi","family":"Santa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromitsu","family":"Yokota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Yatomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruhiko","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Goto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoji","family":"Tsuji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/mol.110.067256_bib1","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1179\/acb.2001.055","article-title":"Hepatotoxicity related to itraconazole: report of three cases","volume":"56","author":"Adriaenssens","year":"2001","journal-title":"Acta Clin Belg"},{"key":"10.1124\/mol.110.067256_bib2","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1097\/FPC.0b013e3282f1f12b","article-title":"Tacrine-induced liver damage: an analysis of 19 candidate genes","volume":"17","author":"Alfirevic","year":"2007","journal-title":"Pharmacogenet Genomics"},{"key":"10.1124\/mol.110.067256_bib3","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0006-2952(02)01015-8","article-title":"Inhibition of transport across the hepatocyte canalicular membrane by the antibiotic fusidate","volume":"64","author":"Bode","year":"2002","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/mol.110.067256_bib4","first-page":"G382","article-title":"Expression and characterization of a functional rat liver Na+ bile acid cotransport system in COS-7 cells","volume":"266","author":"Boyer","year":"1994","journal-title":"Am J Physiol"},{"key":"10.1124\/mol.110.067256_bib5","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1053\/gast.2002.36591","article-title":"The human bile salt export pump: characterization of substrate specificity and identification of inhibitors","volume":"123","author":"Byrne","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1124\/mol.110.067256_bib6","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1067\/mcp.2001.114667","article-title":"The endothelin antagonist bosentan inhibits the canalicular bile salt export pump: a potential mechanism for hepatic adverse reactions","volume":"69","author":"Fattinger","year":"2001","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/mol.110.067256_bib7","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S0168-8278(02)00107-1","article-title":"Contribution of mrp2 in alterations of canalicular bile formation by the endothelin antagonist bosentan","volume":"37","author":"Fouassier","year":"2002","journal-title":"J Hepatol"},{"key":"10.1124\/mol.110.067256_bib8","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0026-895X(24)12255-9","article-title":"Cholestatic potential of troglitazone as a possible factor contributing to troglitazone-induced hepatotoxicity: in vivo and in vitro interaction at the canalicular bile salt export pump (Bsep) in the rat","volume":"59","author":"Funk","year":"2001","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.110.067256_bib9","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/j.1365-4362.1995.tb02962.x","article-title":"Hepatotoxicity associated with itraconazole","volume":"34","author":"Gallardo-Quesada","year":"1995","journal-title":"Int J Dermatol"},{"key":"10.1124\/mol.110.067256_bib10","doi-asserted-by":"crossref","first-page":"10046","DOI":"10.1074\/jbc.273.16.10046","article-title":"The sister of P-glycoprotein represents the canalicular bile salt export pump of mammalian liver","volume":"273","author":"Gerloff","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.110.067256_bib11","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.cld.2007.06.001","article-title":"Mechanisms of drug-induced liver disease","volume":"11","author":"Gunawan","year":"2007","journal-title":"Clin Liver Dis"},{"key":"10.1124\/mol.110.067256_bib12","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1172\/JCI115154","article-title":"Reversal of daunorubicin resistance in P388\/ADR cells by itraconazole","volume":"87","author":"Gupta","year":"1991","journal-title":"J Clin Invest"},{"key":"10.1124\/mol.110.067256_bib13","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1111\/j.1365-2133.1993.tb03186.x","article-title":"Itraconazole-induced acute hepatitis","volume":"129","author":"Hann","year":"1993","journal-title":"Br J Dermatol"},{"key":"10.1124\/mol.110.067256_bib14","doi-asserted-by":"crossref","first-page":"16","DOI":"10.2133\/dmpk.18.16","article-title":"Potential cholestatic activity of various therapeutic agents assessed by bile canalicular membrane vesicles isolated from rats and humans","volume":"18","author":"Horikawa","year":"2003","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1124\/mol.110.067256_bib15","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1248\/bpb.24.1032","article-title":"Reversal effects of antifungal drugs on multidrug resistance in MDR1-overexpressing HeLa cells","volume":"24","author":"Iida","year":"2001","journal-title":"Biol Pharm Bull"},{"key":"10.1124\/mol.110.067256_bib16","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1111\/j.1872-034X.2009.00544.x","article-title":"Receptor for activated C-kinase 1 regulates the cellular localization and function of ABCB4","volume":"39","author":"Ikebuchi","year":"2009","journal-title":"Hepatol Res"},{"key":"10.1124\/mol.110.067256_bib17","series-title":"Guide for the Care and Use of Laboratory Animals","year":"1996"},{"key":"10.1124\/mol.110.067256_bib18","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0140-6736(92)90527-A","article-title":"Hepatic injury associated with itraconazole","volume":"340","author":"Lavrijsen","year":"1992","journal-title":"Lancet"},{"key":"10.1124\/mol.110.067256_bib19","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the Folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.110.067256_bib20","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1124\/dmd.105.008748","article-title":"Inhibition of bile acid transport across Na+\/taurocholate cotransporting polypeptide (SLC10A1) and bile salt export pump (ABCB 11)-coexpressing LLC-PK1 cells by cholestasis-inducing drugs","volume":"34","author":"Mita","year":"2006","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/mol.110.067256_bib21","doi-asserted-by":"crossref","first-page":"G159","DOI":"10.1152\/ajpgi.00360.2003","article-title":"Vectorial transport of bile salts across MDCK cells expressing both rat Na+-taurocholate cotransporting polypeptide and rat bile salt export pump","volume":"288","author":"Mita","year":"2005","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1124\/mol.110.067256_bib22","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/hep.21591","article-title":"Bile salt-dependent efflux of cellular phospholipids mediated by ATP binding cassette protein B4","volume":"46","author":"Morita","year":"2007","journal-title":"Hepatology"},{"key":"10.1124\/mol.110.067256_bib23","doi-asserted-by":"crossref","first-page":"779","DOI":"10.2165\/0003088-200847120-00003","article-title":"The enzymatic basis of drug-drug interactions with systemic triazole antifungals","volume":"47","author":"Nivoix","year":"2008","journal-title":"Clin Pharmacokinet"},{"key":"10.1124\/mol.110.067256_bib24","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1053\/gast.2002.36587","article-title":"Functional expression of the canalicular bile salt export pump of human liver","volume":"123","author":"No\u00e9","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1124\/mol.110.067256_bib25","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s00424-006-0062-9","article-title":"Function and pathophysiological importance of ABCB4 (MDR3 P-glycoprotein)","volume":"453","author":"Oude Elferink","year":"2007","journal-title":"Pflugers Arch"},{"key":"10.1124\/mol.110.067256_bib26","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1053\/j.gastro.2005.08.052","article-title":"Hepatocanalicular transport defects: pathophysiologic mechanisms of rare diseases","volume":"130","author":"Oude Elferink","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1124\/mol.110.067256_bib27","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/0092-8674(93)90380-9","article-title":"Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease","volume":"75","author":"Smit","year":"1993","journal-title":"Cell"},{"key":"10.1124\/mol.110.067256_bib28","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0014-5793(94)01135-4","article-title":"The human MDR3 P-glycoprotein promotes translocation of phosphatidylcholine through the plasma membrane of fibroblasts from transgenic mice","volume":"354","author":"Smith","year":"1994","journal-title":"FEBS Lett"},{"key":"10.1124\/mol.110.067256_bib29","doi-asserted-by":"crossref","first-page":"23530","DOI":"10.1074\/jbc.M909002199","article-title":"MDR3 P-glycoprotein, a phosphatidylcholine translocase, transports several cytotoxic drugs and directly interacts with drugs as judged by interference with nucleotide trapping","volume":"275","author":"Smith","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.110.067256_bib30","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1191\/0960327104ht479oa","article-title":"Hepatotoxicity induced by antifungal drugs itraconazole and fluconazole in rats: a comparative in vivo study","volume":"23","author":"Somchit","year":"2004","journal-title":"Hum Exp Toxicol"},{"key":"10.1124\/mol.110.067256_bib31","first-page":"170","article-title":"Hepatotoxicity of antifungal agents","volume":"6","author":"Song","year":"2005","journal-title":"Curr Opin Investig Drugs"},{"key":"10.1124\/mol.110.067256_bib32","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1468-3083.2005.00943.x","article-title":"Liver failure and transplantation after itraconazole treatment for toenail onychomycosis","volume":"19","author":"Srebrnik","year":"2005","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1124\/mol.110.067256_bib33","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/S0016-5085(00)70224-1","article-title":"Drug- and estrogen-induced cholestasis through inhibition of the hepatocellular bile salt export pump (Bsep) of rat liver","volume":"118","author":"Stieger","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1124\/mol.110.067256_bib34","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1248\/bpb.22.1355","article-title":"Cellular pharmacokinetic aspects of reversal effect of itraconazole on P-glycoprotein-mediated resistance of anticancer drugs","volume":"22","author":"Takara","year":"1999","journal-title":"Biol Pharm Bull"},{"key":"10.1124\/mol.110.067256_bib35","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/j.jhep.2005.09.017","article-title":"Potential role of trans-inhibition of the bile salt export pump by progesterone metabolites in the etiopathogenesis of intrahepatic cholestasis of pregnancy","volume":"44","author":"Vallejo","year":"2006","journal-title":"J Hepatol"},{"key":"10.1124\/mol.110.067256_bib36","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0092-8674(00)81370-7","article-title":"MDR1 P-glycoprotein is a lipid translocase of broad specificity, while MDR3 P-glycoprotein specifically translocates phosphatidylcholine","volume":"87","author":"van Helvoort","year":"1996","journal-title":"Cell"},{"key":"10.1124\/mol.110.067256_bib37","first-page":"175","article-title":"[Thin layer chromatography of phosphatides and glycolipids.]","volume":"334","author":"Wagner","year":"1961","journal-title":"Biochem Z"},{"key":"10.1124\/mol.110.067256_bib38","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1023\/A:1023278211849","article-title":"Fluorescent substrates of sister-P-glycoprotein (BSEP) evaluated as markers of active transport and inhibition: evidence for contingent unequal binding sites","volume":"20","author":"Wang","year":"2003","journal-title":"Pharm Res"},{"key":"10.1124\/mol.110.067256_bib39","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1073\/pnas.98.4.2011","article-title":"Targeted inactivation of sister of P-glycoprotein gene (spgp) in mice results in nonprogressive but persistent intrahepatic cholestasis","volume":"98","author":"Wang","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/mol.110.067256_bib40","first-page":"18","article-title":"An open randomized parallel-comparison study of itraconazole oral solution versus itraconazole capsules in treatment of patients with oropharyngeal candidiasis","volume":"54","author":"Yamaguchi","year":"2006","journal-title":"Jpn J Chemother"},{"key":"10.1124\/mol.110.067256_bib41","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0090-9556(24)14917-3","article-title":"Quantitative prediction of metabolic inhibition of midazolam by itraconazole and ketoconazole in rats: implication of concentrative uptake of inhibitors into liver","volume":"27","author":"Yamano","year":"1999","journal-title":"Drug Metab Dispos"}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24028803?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24028803?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/mol.110.067256","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T04:49:52Z","timestamp":1739940592000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X24028803"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["S0026895X24028803"],"URL":"https:\/\/doi.org\/10.1124\/mol.110.067256","relation":{},"ISSN":["0026-895X"],"issn-type":[{"value":"0026-895X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Itraconazole-Induced Cholestasis: Involvement of the Inhibition of Bile Canalicular Phospholipid Translocator MDR3\/ABCB4","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/mol.110.067256","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2011 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}